Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings News Story

HK$1.4 0.0  1.5%

Last Trade - 8:45am

Sector
Consumer Defensives
Size
Small Cap
Market Cap £106.8m
Enterprise Value £95.1m
Revenue £178.5m
Position in Universe 3184th / 6099

BRIEF-Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB138.5 Mln Vs RMB114.7 Mln

Thu 25th March, 2021 1:27am
March 25 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
 3737.HK :
    * FY PROFIT ATTRIBUTABLE RMB138.5 MILLION VERSUS RMB114.7
MILLION
    * FY REVENUE RMB1.60 BILLION VERSUS RMB1.34 BILLION
    * PROPOSED SPECIAL INTERIM DIVIDEND HK1.45 CENTS PER SHARE
    * PROPOSED INTERIM DIVIDEND HK3.70 CENTS PER SHARE

Source text for Eikon:  ID:nHKSc8x0yF 
Further company coverage:  3737.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.